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Abstract
Background: A spectrum effect was defined as differences in the sensitivity or specificity of a
diagnostic test according to the patient's characteristics or disease features. A spectrum effect can
lead to a spectrum bias when subgroup variations in sensitivity or specificity also affect the
likelihood ratios and thus post-test probabilities. We propose and illustrate a methodological
framework to distinguish spectrum effects from spectrum biases.
Methods: Data were collected for 1781 women having had a cervical smear test and colposcopy
followed by biopsy if abnormalities were detected (the reference standard). Logistic models were
constructed to evaluate both the sensitivity and specificity, and the likelihood ratios, of the test and
to identify factors independently affecting the test's characteristics.
Results: For both tests, human papillomavirus test, study setting and age affected sensitivity or
specificity of the smear test (spectrum effect), but only human papillomavirus test and study setting
modified the likelihood ratios (spectrum bias) for clinical reading, whereas only human
papillomavirus test and age modified the likelihood ratios (spectrum bias) for "optimized"
interpretation.
Conclusion:  Fitting sensitivity, specificity and likelihood ratios simultaneously allows the
identification of covariates that independently affect diagnostic or screening test results and
distinguishes spectrum effect from spectrum bias. We recommend this approach for the
development of new tests, and for reporting test accuracy for different patient populations.
Background
"Spectrum bias" in diagnostic test evaluation was first
reported by Ransohoff and Feinstein in 1978 [1]. They
observed that the sensitivity and specificity of diagnostic
tests could differ between subgroups of patients with dif-
ferent characteristics, including severity and location of
the disease or clinical features. Since this pioneering
study, many authors have described such differences in
performance for numerous tests in various contexts (e.g.
[2-14]). It has been recommended that authors report
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estimates of variability of diagnostic accuracy between
subgroups of patients affected by these differences in per-
formance and this was recently endorsed by the STARD
Initiative [15,16]. However, other authors have expressed
scepticism regarding the evaluation of accuracy of diag-
nostic or screening tests, to the point of considering them
"unpredictable" as their accuracy may depend on too
many factors [17,18], and the use the post test probabili-
ties (PTP) as indicators of test accuracy has been proposed
[13].
As the literature became increasingly confused, the recent
paper by Goehring et al. [19] represented an important
breakthrough by drawing attention to the need for distin-
guishing between various "spectrum effects". Having
defined "spectrum effect" as differences in the sensitivity
or specificity of a diagnostic or screening test according to
the patient's characteristics or to the features and severity
of the disease, Goehring et al. showed that a "spectrum
effect" can lead to a spectrum bias when subgroup varia-
tions in sensitivity or specificity also affect the likelihood
ratios and thus post-test probabilities (see also [9,11,20]).
Indeed, there are some situations for which subgroup
analyses of sensitivity and specificity do not lead to the
same conclusions as subgroup analyses for likelihood
ratios. For example, conflicting results can be obtained
when there is no variation in sensitivity and specificity
between subgroups, but a higher prevalence of the disease
in one subgroup than another. Conversely, variations in
sensitivity and specificity do not mechanically imply
biased results if one considers the "overall" test character-
istics [19]. As sensitivity and specificity are inversely
related, differences between subgroups do not necessarily
affect likelihood ratios (and therefore post-test probabili-
ties). Unfortunately, the term "bias" in "spectrum bias"
may be misleading, as "bias" usually refers to the lack of
validity of results due to inadequate study design (e.g.
using a diagnostic case-control design to select patients
rather than a diagnostic cohort design) and inadequate
spectrum selection (e.g. by assessing an inappropriate
group of patients given the study objective) [14,21]. Nev-
ertheless we will conform to the work of Goehring et al.
[19] and use this term herein because of its other classical
meaning, which is statistical, regarding the use of an esti-
mator giving wrong estimations: indeed, the post-test
probabilities of diseases would be biased (and thus the
clinical decision altered) if the appropriate group-specific
performance values of the test are not used.
Goehring et al. [19] only proposed stratified analysis of
spectrum effects and biases. The recent logistic regression
approach by Janssens et al. [22] is complementary to that
developed more than twenty years ago by Hlatky [2] and
subsequently by Coughlin [23] and Moons [9] (among
others) and extends this analysis to multivariable cases.
Such multivariable analyses are necessary because factors
responsible for differences in performance of tests are gen-
erally numerous and closely related.
Here, we propose a methodological framework, derived
from the approaches described (both applied together for
the first time), to distinguish spectrum effects from spec-
trum biases. Our purpose is to isolate factors independ-
ently affecting the diagnostic accuracy of a test. This
approach is illustrated by an application to the Papanico-
laou smear test for detection of cervical cancer.
Methods
Data sources
We undertook a secondary analysis of the study by the
French Society of Clinical Cytology to compare the effi-
ciency of the conventional Papanicolaou smear, ThinPrep
liquid-based cytology and the Hybrid-Capture II human
papillomavirus test (HPV test) [24-26]. The design of the
study was described in detail elsewhere [24]. This analysis
focuses on one of the three tests, the conventional Papan-
icolaou smear test, and the spectrum variations associated
with it. All women included in this study (n = 1781) were
evaluated by the reference standard (colposcopy followed
by biopsy if abnormalities were detected), by the index
test (conventional Papanicolaou smear test) and by the
HPV test (which was considered in this analysis as a "spec-
trum" variable). These women were either referred for col-
poscopy because abnormalities had been detected on
previous smears (referral clinic setting, n = 461) or were
attending for routine smears (screening setting, n = 1320).
Conventional Papanicolaou smear tests were read twice:
in addition to routine reading in normal conditions
("clinical reading"), a reading blind to the context and
clinical history was obtained for Papanicolaou test smears
separately and independently by two different patholo-
gists. In cases of disagreement, the slides were read again
to reach a consensus conclusion, with a decision given, if
necessary, by an independent expert ("optimized diagno-
sis"). Smear test results were classified as negative (normal
smear or atypical squamous cells/glandular cells of unde-
termined significance (ASCUS/AGUS)) or positive (low
grade or high grade squamous intraepithelial lesions or
invasive cancer) according to the 1991 Bethesda system
[27]. The reference standard results were classified as neg-
ative (normal colposcopy or negative biopsy result) or
positive (cervical intraepithelial neoplasia of grade I, II or
III or invasive carcinoma) according to the International
Federation of Cervical Pathology and Colposcopy classifi-
cation system [28]. The validity of these cutoff points may
be open to discussion, but they were used in our previous
papers and classify a sufficient number of patients with
significant lesions. Other characteristics of the women
were also recorded: age, current smoking, European orBMC Medical Research Methodology 2008, 8:7 http://www.biomedcentral.com/1471-2288/8/7
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other origin, educational level, menopausal status and
contraception status.
Statistical analysis
Sensitivity, specificity and likelihood ratios were used as
indicators of test accuracy. Stratified analyses of these
indicators were performed for the following variables:
HPV test, study setting (referral clinic or screening), age (<
or ≥ 35 years), current smoking, European origin, educa-
tional level (higher education or less), menopausal status
and contraception status (none, combined oral pill or
other). Confidence intervals for sensitivity and specificity
were produced with the Wilson score method without
continuity correction [29]. Confidence intervals for posi-
tive and negative likelihood ratios were calculated by the
method described by Simel et al. [30]. Logistic regression
models were also constructed for sensitivity and specifi-
city and the likelihood ratios to evaluate spectrum effects
and spectrum biases associated with these variables.
The logistic model for sensitivity and specificity proposed
by Coughlin et al. [23] was used to estimate sensitivity
and specificity by defining the dependent variable as the
dichotomous result of the diagnostic test. The presence of
the disease defined by the reference standard is included
as a binary explanatory variable, as are covariates poten-
tially affecting sensitivity or specificity (Additional file 1).
Interaction terms between the reference standard and cov-
ariates were also included to test whether the covariates
affect sensitivity and specificity differentially.
The approach proposed by Janssens et al. [22] was used to
estimate the likelihood ratios of a diagnostic test results
conditional to covariates. It requires the construction of
logistic models for the "prior odds" of the disease and one
for "posterior odds" of the disease. The prior odds regres-
sion model includes only the covariate(s). The posterior
odds regression model also includes the binary result of
the diagnostic test and interaction terms between the diag-
nostic test and covariate(s), which indicate if the covari-
ates affect the positive and the negative likelihood ratios
differentially (Additional file 1). The likelihood ratios for
the result of the diagnostic test conditional on the values
of the covariates were further obtained by subtracting the
coefficients of the prior odds regression model from the
coefficients of the posterior odds regression model [22].
Confidence intervals for the differences in logistic regres-
sion coefficients were approximated by a bootstrap tech-
nique with 2000 random bootstrap samples with
replacement [31].
All multivariable regression models initially included cov-
ariates modifying the test accuracy indicators with a p-
value of 0.20 or less in logistic regression univariable anal-
yses and first-order interactions between these covariates
and the disease status (according to the diagnostic test or
the reference standard). Final models were obtained by a
grouped backward stepwise selection procedure. At each
step, the variable with the least significant main effect was
removed from the model if its interaction terms were asso-
ciated with a p-value greater than 0.05. Even if not signif-
icant, all first-order interactions (for variables with a
significant main effect) were conserved in the final model
to obtain less biased estimations of group-specific likeli-
hood ratios, as recommended by Janssens et al. [22].
All analyses were performed using SAS software version 8
[32].
Results
Among the 1781 women included, 355 scored positive
with the conventional Papanicolaou smear test (20%).
Table 1 presents the characteristics of the 1781 women
included and the results of stratified analysis of sensitivity,
specificity and likelihood ratios. The smear test's accuracy
differed substantially between subgroups, in particular for
HPV test and study setting, both for clinical and opti-
mized readings.
Table 2 provides a summary of univariable and multivar-
iable results for sensitivity, specificity and likelihood
ratios. For the sake of simplicity, this table reports only
effects with p-values of less than 0.2. Several covariates
modified sensitivity or specificity but few affected the like-
lihood ratio(s). The multivariable modelling allowed the
number of covariates affecting diagnostic accuracy to be
decreased by removing non-independent factors (current
smoking, European origin or educational level) that were
related to sensitivity and specificity or likelihood ratios
through HPV test, age or study setting. For both clinical
and optimized readings, HPV test, study setting and age
affected specificity and sensitivity independently. For the
clinical reading, HPV test and study setting were both
responsible for a spectrum bias whereas age had no effect
on likelihood ratios. For the optimized interpretation, the
HPV test and age were the only two factors responsible for
a spectrum bias.
Additional files 2 and 3 contains details about the sensi-
tivity, specificity (Additional file 2) and likelihood ratios
(Additional file 3) of the final models for clinical reading.
Discussion
We propose a methodological framework for identifying
factors independently responsible for spectrum effects
(i.e. which affect the sensitivity and specificity only) and
for spectrum biases (i.e. which affect the likelihood ratios
and post-test probabilities). This framework consists of
double modelling, of sensitivity/specificity and positive/
negative likelihood ratios respectively and thereforeBMC Medical Research Methodology 2008, 8:7 http://www.biomedcentral.com/1471-2288/8/7
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Table 1: Subgroup analysis of the sensitivity, specificity and likelihood ratios of the Papanicolaou smear test
Clinical reading (n = 1781) Optimized interpretation (n = 1777)
Variables† n
(%)
Disease
prevalence n
(%)
Sensitivity % Specificity % Positive
likelihood
ratio
Negative
likelihood
ratio
Sensitivity % Specificity % Positive
likelihood
ratio
Negative
likelihood
ratio
HPV test
Positive 537 (30) 282 (53) 95 76 4.02 0.07 92 76 3.93 0.10
Negative 1244 (70) 73 (6) 64 93 9.31 0.38 64 93 8.85 0.38
Study setting
Screening 1320 (74) 70 (5) 70 94 12.32 0.32 75 92 8.96 0.27
Referral clinic 461 (26) 285 (62) 93 60 2.34 0.12 89 77 3.90 0.14
Age
<35 years 981 (55) 158 (16) 89 92 11.66 0.12 83 91 9.44 0.19
≥ 35 years 800 (45) 197 (25) 88 87 6.79 0.14 89 88 7.37 0.12
Current 
smoking
Yes 602 (34) 161 (27) 90 88 7.22 0.11 87 89 7.67 0.15
No 1161 (66) 188 (16) 87 91 9.98 0.14 87 90 8.94 0.15
European origin
Yes 1623 (91) 312 (19) 88 91 9.71 0.13 87 90 8.81 0.15
No 158 (9) 43 (27) 91 81 4.74 0.11 83 86 5.99 0.19
Educational level
< Higher 1063 (60) 227 (21) 88 87 7.15 0.14 87 88 7.31 0.15
≥ Higher 709 (40) 128 (18) 89 93 14.38 0.12 86 92 11.06 0.15
Postmenopausal
Yes 174 (10) 44 (25) 86 88 7.49 0.15 93 91 10.09 0.08
No 1607 (90) 311 (19) 89 90 9.13 0.12 85 90 8.31 0.16
Contraception
None 640 (36) 127 (20) 89 89 8.30 0.12 87 90 8.93 0.14
Combined 
oral pill
905 (51) 173 (19) 87 91 9.26 0.14 83 90 8.50 0.19
Others 236 (13) 55 (23) 91 91 9.68 0.10 96 87 7.27 0.04
† Data were missing for the following variables: current smoking (18 patients) and educational level (9 patients).
Significant comparisons are indicated in bold.
Table 2: Summary of univariable and multivariable regression analyses for sensitivity/specificity and likelihood ratios of the 
Papanicolaou smear test (only p-values less than 0.20 are presented)
Univariable analyses Multivariable analyses
Clinical reading Optimized interpretation Clinical reading Optimized interpretation
Sensitivity Specificity† Likelihood ratios‡ Sensitivity Specificity† Likelihood ratios‡ Sensitivity Specificity† Likelihood ratios‡ Sensitivity Specificity† Likelihood ratios‡
Variables Main 
effect
Interaction Main 
effect
Interaction Main 
effect
Interaction Main 
effect
Interaction Main 
effect
Interaction Main 
effect
Interaction Main 
effect
Interaction Main 
effect
Interaction
HPV test <0.001 0.03 <0.00
1
0.033 <0.001 0.18 <0.001 0.18 <0.001 0.09 <0.001 0.011 <0.001 0.15 <0.001 0.17
Study setting <0.001 0.10 0.001 0.11 <0.001 - 0.023 - <0.001 0.14 0.015 - <0.001 -
Age 0.001 0.06 - 0.07 0.04 - 0.12 - 0.026 - 0.045 - 0.047 -
Current smoking 0.03 - - - - - - -
European origin <0.001 - - - 0.17 - - -
Educational level <0.001 0.035 - 0.043 0.014 - - -
Postmenopausal - - - - - 0.17 - -
Contraceptive 
status
---- - - - -
HPV: human papillomavirus.
† For the sensitivity/specificity model: interaction between the variable and the reference standard (see Additional file 1)
‡ For the likelihood ratios model: interaction between the variable and the diagnostic test (see Additional file 1).BMC Medical Research Methodology 2008, 8:7 http://www.biomedcentral.com/1471-2288/8/7
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extends the stratified analysis of spectrum effects and
biases proposed by Goehring et al. [19], taking into
account the fact that these factors are generally numerous
and closely related. We demonstrated the usefulness of
this framework by application to Papanicolaou smear
testing for the detection of cervical cancer. With this
approach, we were able to differentiate the covariates
linked to disease prevalence or severity and true "test
modifiers" (modifying the test results due to their own
effect, as HPV and age should do) from others factors
affecting test accuracy only through "test modifiers" (for
example current smoking, European origin and educa-
tional level). The massive and consistent effect of the HPV
test result on Papanicolaou smear test results can be
explained by the influence of the virus on cellular features.
Disease prevalence and/or severity have a well-known
effect on test accuracy indices [33]. Indeed, high risk (or
oncogenic) HPV is the cause of cervical cancer develop-
ment and is currently considered as a marker of severity of
intraepithelial lesions [34,35]. The study setting was
found to be responsible for spectrum bias only for clinical
reading, confirming the information bias (or clinical
review bias) observed for reading not blind to the context
and clinical history. The strong effect of study setting
probably masked the effect of age on the clinical reading,
as age appeared to be responsible for spectrum bias only
in optimized reading (where information bias was neu-
tralized).
Many authors report differences in diagnostic or screening
test accuracy between subgroups, but few have used a
multivariable modelling approach to identify factors
responsible for differences in the performance of tests and
confounding factors. A review of current practice, includ-
ing investigations of so-called spectrum bias (Table 3),
shows that a large number of factors have been investi-
gated, often without discernment but frequently with con-
fusion regarding their significance to test accuracy.
Moreover, most of these studies analyzed test accuracy
only in terms of sensitivity and specificity [6-8,36-40],
making it impossible to distinguish between spectrum
effect and spectrum bias.
Our framework nevertheless presents some difficulties,
mainly due to having to use non-trivial regression model-
ling. In particular, the simultaneous fitting of prior and
posterior odds of the disease could be considered com-
plex, as could the use of bootstrapping methods to con-
struct confidence intervals for coefficients. Another
difficulty is the management of interaction terms and the
risk of colinearity between covariates included in the
models. We chose to include only first order interactions
between covariates and the disease status (according to
the diagnostic test or the reference standard) because
these interactions were the only ones relevant in the con-
text of the differences in performance of a diagnostic or
screening test. Usual recommendations concerning the
practical implementation of regression analysis methods
remain helpful in this context [41,42]. In particular, atten-
tion must be paid to the lack of power of the interaction
test and its interpretation: the logistic model for sensitivity
and specificity includes diseased and non-diseased
patients and gives results closer to the sensitivity when the
proportion of non-diseased patients is high, as is the case
here. For example, we observe "paradoxical" results for
current smoking, which is a significant predictor of sensi-
tivity and specificity in the univariable analysis for clinical
reading (Table 2, the interaction term is not significant),
but with confidence intervals inconsistent with this con-
clusion. However, the use of a multivariable approach
does not negate recommendations about patient selection
or eliminate the necessity for carefully defined and rele-
vant inclusion criteria – a spectrum of patients needs to be
included that is similar to the population in which the test
will be used in practice [15,16,43].
Conclusion
In conclusion, we have shown the value of complemen-
tary and simultaneous modelling of sensitivity, specificity
and likelihood ratios in logistic regression models: this
approach can identify covariates that independently affect
the accuracy of a diagnostic or screening test and can dis-
tinguish spectrum bias from spectrum effects. This
approach appears preferable to subgroup analyses, which
are classically recommended [15,16] but for which the
problems are well known [44]: the number of patients per
group is often small, especially if the number of covariates
is high, leading to analyses that are not very powerful or
accurate and problems of interpretation. As in therapeutic
research [45-47], approaches based on regression model-
ling (and interaction testing) should replace subgroup
analysis for the development of diagnostic and screening
tests and for reporting their accuracy.
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Table 3: Studies that investigated subgroup variations*
Study, Year Approach to the 
analysis of 
spectrum bias/
effect
Disease 
(number of 
subjects)
Diagnostic or 
screening test
Factors 
investigated
Effect on 
sensitivity and/or 
specificity
Effect on 
Likelihood 
ratios
Van der schouw, 1995 [5] Subgroup analysis Epididymitis 
(372)
Ultrasonography Disease 
prevalence 
(severity 
according to 
clinician)
Disease 
prevalence 
(severity 
according to 
clinician)
Disease 
prevalence 
(severity 
according to 
clinician)
Morise, 1995 [36] Subgroup analysis Coronary 
disease (4467)
Exercise 
electrocardiography
Sex Verification by 
the gold standard 
(angiography) or 
not
Sex Verification 
bias by the gold 
standard 
(angiography) or 
not
Not considered
O'Connor, 1996 [6] Subgroup analysis Multiple 
sclerosis (303)
Magnetic resonance 
imaging and evoked 
potentials
Study group (two 
pooled studies 
considered), 
disease 
prevalence, clinical 
subjective disease 
probability
Study group, 
disease 
prevalence, 
clinical subjective 
disease 
probability
Not considered
Egglin, 1996 [37] Subgroup analysis Pulmonary 
embolism (24)
Pulmonary 
arteriogram
Disease 
prevalence
Disease 
prevalence
Not considered
Roger, 1997 [8] Subgroup analysis Coronary 
disease (3679)
Exercise 
echocardiography
Sex Sex Not considered
Curtin, 1997 [7] Subgroup analysis Obesity (226) Body mass index Weight, sex Weight, sex Not considered
Moons, 1997 [9] Subgroup analysis 
and modelling of 
sensitivity
Coronary 
disease (295)
Exercise test Patient history 
and clinical 
examination, 
various disease-
related factors 
(maximal load, 
relative load, 
systolic blood 
pressure, number 
of diseased 
vessels)
Sex, expected 
load, maximal 
load, relative 
load, systolic 
blood pressure 
(baseline and 
peak), number of 
diseased vessels
Age, sex, 
symptoms, 
smoking, beta 
blocker use, 
cholesterol 
level, expected 
load, maximal 
load, relative 
load, systolic 
blood pressure 
(baseline and 
peak)
Santana-Bodao, 1998 [38] Subgroup analysis Coronary 
disease (702)
Single-photon 
emission computed 
tomography
Sex Sex Not considered
Steinbauer, 1998 [10] Subgroup analysis Alcohol abuse 
(1333)
Various screening 
tests
Race and sex Race and sex Race and sex
DiMatteo, 2001 [39] Subgroup analysis Group A beta 
haemolytic 
streptococcal 
pharyngitis (498)
Rapid antigen 
detection test
Disease severity Disease severity Not considered
Filly, 2002 [48] Subgroup analysis 
and modelling
Cirrhosis (100) Nodularity of 
surfaces of the liver
Deep versus 
superficial surfaces
Deep versus 
superficial 
surfaces
Age, sex, 
pathological 
type of cirrhosis
Hall, 2004 [40] Subgroup analysis 
and modelling
Group A beta 
haemolytic 
streptococcal 
pharyngitis (561)
Rapid antigen 
detection test
Disease severity Disease severity Not considered
Meideros, 2005 [49] Subgroup analysis Glaucoma (136) Scanning laser 
polarimetry
Two forms of 
glaucomatous 
optic neuropathy
Two forms of 
glaucomatous 
optic neuropathy
Two forms of 
glaucomatous 
optic 
neuropathy
* Papers published between 1978 and 2000 were identified from the systematic review by Whiting et al [14]. Papers published between 2000 and 
2005 were similarly selected through Medline® using the keywords: diagnostic, test, screening, performance, accuracy, sensitivity, specificity, likelihood ratio, 
spectrum, subgroup, bias, prevalence, accuracy. Only primary studies investigating variations in diagnostic test performances between subgroups were 
considered. Letters were excluded.BMC Medical Research Methodology 2008, 8:7 http://www.biomedcentral.com/1471-2288/8/7
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